Peptobiotics has raised a USD 6.2 million Series A to commercialize its antimicrobial peptide technology to replace the use of antibiotics.
Kent Swisher, president, and CEO of NARA has been elected to the GFLI Board of Directors, while Charles Starkey, vice president of Scientific and Regulatory Affairs at NARA, has been appointed to the GFLI Technical Management Committee.
Mike Kocsis, who joined the organization in April 2022 as chief systems officer, was most recently promoted to chief strategy officer in August 2023 and now CEO.
Julia Dvorska will oversee the expansion of the company’s feed additives in the area.
Once the works have been completed and the necessary authorization has been obtained, the facilities in Galicia will produce 12,000 tonnes of larvae per year.
Sequence™, a foundational feed ingredient produced at scale using proprietary mechanical separation technology, delivers a combination of corn and yeast protein, concentrated at a minimum of 60%.
A study concluded that krill meal inclusion resulted in positive effects on Nile tilapia’s reproductive performance and higher survival of larvae.
USDA-APHIS determined that Yield10 Bioscience’s omega-3 camelina varieties may be planted and bred in the United States.
The companies aim to boost sustainable animal feed production, enhance animal feed nutrition for optimal health and performance, and promote efficient waste utilization through a biogas project.
ASC will focus and invest in the coming years in regions, markets and activities where it believes it can have the greatest impact.
Results showcase the company’s commitment to people, communities and animal wellbeing.
The technology could be scaled up to make mass antigens available to later be applied via salmon feeds as an oral vaccine.
The MoU aims to establish a sustainable and dependable supply chain for soybean, soybean meal and soy products for the Thai feed milling community.
The partnership aims to remove existing barriers and empower the entire agri-food ecosystem to adopt more sustainable practices.
In the multi-purpose center, customers from the food and animal feed sectors can conduct trials on new products and explore new processes and solutions.
Similar animal performance was achieved in all 19 trials when 100 units of methionine hydroxy analog products were replaced with 65 units of MetAMINO®.
Promising new technology developed by microXpace and Lallemand Animal Nutrition is ready to move to the product development phase.
The joint venture established by Evonik and Vland Biotech aims to develop and expand gut health solutions products, including probiotics, for farm animals in China.
The new funding will support Kuehnle AgroSystems’ plans to reach commercialization this year.
Gerred Fuchs will support product development and strengthen technical support across Brazil, India, and Turkey.
